GSK plc Increase Decrease Through Business Combinations Deferred Tax Liability Asset
GSK plc (GSK) reported Increase Decrease Through Business Combinations Deferred Tax Liability Asset of GBP 321.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseThroughBusinessCombinationsDeferredTaxLiabilityAsset · last filed 2026-03-06
| Period end | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month | Increase Decrease Through Business Combinations Deferred Tax Liability Asset 12 month as first filed |
|---|---|---|
| 2025-12-31 | 321.00M GBP 20-F · filed 2026-03-06 | |
| 2024-12-31 | 190.00M GBP 20-F · filed 2026-03-06 | -190.00M GBP 20-F · filed 2025-03-03 |
| 2023-12-31 | -144.00M GBP 20-F · filed 2025-03-03 | |
| 2022-12-31 | -495.00M GBP 20-F · filed 2024-03-05 | |
| 2021-12-31 | -1.00M GBP 20-F · filed 2023-03-10 | |
| 2020-12-31 | -25.00M GBP 20-F · filed 2022-03-08 | |
| 2019-12-31 | -2.84B GBP 20-F · filed 2021-03-12 |